Summary:
Killer Ig-like receptor (KIR) is a major cluster of the natural killer cell receptors and may play a role in the outcome of hematopoietic cell transplants. A total of 65 AML cases transplanted with T-replete hematopoietic cells from unrelated donors were retrospectively KIR-genotyped by a multiplex PCR method of our own design. The KIR gene frequency and genotype patterns in these 130 samples were consistent with the data in the literature. Based upon overall inhibitory and activating KIR genes in both donors and patients, we developed an algorithm to calculate a compatibility score for each transplant case as plus, zero or minus. Significantly higher incidence (18/20, 90%) of acute (a) GVHD (grade II–IV) was found in the transplant cases with plus scores than that (25/45, 56%) in the cases with zero or minus scores (P<0.01). When the scores are sorted in the opposite way, fewer cases (13/26, 50%) of aGVHD were found in the transplants with minus scores than that (30/39, 77%) in the transplants with zero or plus scores (P<0.05). The difference of aGVHD prevalence between the plus score and minus score groups is highly significant (P<0.01). KIR genotype compatibility calculated by this algorithm may predict aGVHD incidence and be helpful in choosing donors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Parham P, McQueen KL . Alloreactive killer cells: hindrance and help for haematopoietic transplants. Nat Rev Immunol 2003; 3: 108–122.
Hamerman JA, Ogasawara K, Lanier LL . NK cells in innate immunity. Curr Opin Immunol 2005; 17: 29–35.
Castriconi R, Della Chiesa M, Moretta A . Shaping of adaptive immunity by innate interactions. C R Biol 2004; 327: 533–537.
Young NT . Immunobiology of natural killer lymphocytes in transplantation. Transplantation 2004; 78: 1–6.
Hsu KC, Keever-Taylor CA, Wilton A et al. Improved outcome in HLA-identical sibling hematopoietic stem cell transplantation for acute myelogenous leukemia (AML) predicted by KIR and HLA genotypes. Blood 2005 [Epub ahead of print].
Barao I, Murphy WJ . The immunobiology of natural killer cells and bone marrow allograft rejection. Biol Blood Marrow Transplant 2003; 9: 727–741.
Carrington M, Norman P . The KIR Gene Cluster. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information. 2003 (Available on www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowTOC&rid=mono_003.TOC&depth=2).
Marsh SG, Parham P, Dupont B et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Hum Immunol 2003; 64: 648–654.
Middleton D, Curran M, Maxwell L . Natural killer cells and their receptors. Transpl Immunol 2002; 10: 147–164.
Borrego F, Kabat J, Kim DK et al. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol Immunol 2002; 38: 637–660.
Dupont B, Hsu KC . Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation. Curr Opin Immunol 2004; 16: 634–643.
Moretta L, Moretta A . Killer immunoglobulin-like receptors. Curr Opin Immunol 2004; 16: 626–633.
Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097–2100.
Giebel S, Locatelli F, Lamparelli T et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003; 102: 814–819.
Beelen DW, Ottinger H, Ferencik S et al. Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias. Blood 2004; 105: 2594–2600.
Davies SM, Ruggieri L, DeFor T et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor. Blood 2002; 100: 3825–3827.
Bornhauser M, Schwerdtfeger R, Martin H et al. Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors. Blood 2004; 103: 2860–2861 (letter).
Schaffer M, Malmberg KJ, Ringden O et al. Increased infection-related mortality in KIR-ligand-mismatched unrelated allogeneic hematopoietic stem-cell transplantation. Transplantation 2004; 78: 1081–1085.
Malmberg KJ, Schaffer M, Ringden O et al. KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation. Mol Immunol 2005; 42: 531–534.
Cook MA, Milligan DW, Fegan CD et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 2004; 103: 1521–1526.
Gagne K, Brizard G, Gueglio B et al. Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum Immunol 2002; 63: 271–280.
Bishara A, De Santis D, Witt CC et al. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens 2004; 63: 204–211.
Cook MA, Briggs DC, Craddock CF et al. Transplant donor KIR genotype influences the rate of CMV reactivation following T-replate stem cell transplantation. Blood 2004; 104 (Suppl. 1): 58a (abstract 188).
Mancusi A, Ruggeri L, McQueen K et al. Donor activating KIR genes and survival after haplo-identical hematopoietic transplantation. Blood 2004; 104 (Suppl. 1): 610a (abstract 2219).
Demanet CJ, Verheyden SJ, Schots RJ . A defined donor activating natural killer cell receptor phenotype protects against leukemic relapse after HLA-identical hematopoietic stem cell transplantation. Blood 2004; 104 (Suppl. 1): 912a (abstract 3338).
Sun JY, Gaidulis L, Miller MM et al. Development of a multiplex PCR-SSP method for Killer-cell immunoglobulin-like receptor genotyping. Tissue Antigens 2004; 64: 462–468.
Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295–304.
Norman PJ, Stephens HA, Verity DH et al. Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics 2001; 52: 195–205.
Uhrberg M, Parham P, Wernet P . Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 2002; 54: 221–229.
Williams F, Meenagh A, Sleator C, Middleton D . Investigation of killer cell immunoglobulinlike receptor gene diversity: I. KIR2DL4. Hum Immunol 2004; 65: 31–38.
Sun JY, Gaidulis L, Dagis A et al. An algorithm calculating KIR genotype compatibility to predict outcomes of hematopoietic cell transplants (HCTs). Hum Immunol 2004; 65 (Suppl. 1): S16 (abstract 25-OR).
Shanmugaapriya S, Mathews V, Kavitha ML et al. Effect of KIR genotype on outcome of related HLA identical stem cell transplant in patients with β Thalassaemia major. Blood 2004; 104 (Suppl. 1): 912a (abstract 3337).
Loiseau P, Chen C, Appert ML et al. The presence and number of activatory KIR (R+D−) impact the infection and survival status of patients transplanted with an HLA-matched sibling donor. Blood 2004; 104 (Suppl. 1): 912a (abstract 3339).
Backstrom E, Kristensson K, Ljunggren HG . Activation of natural killer cells: underlying molecular mechanisms revealed. Scand J Immunol 2004; 60: 14–22.
Verheyden S, Bernier M, Demanet C . Identification of natural killer cell receptor phenotypes associated with leukemia. Leukemia 2004; 18: 2002–2007.
Arnheim L, Dillner J, Sanjeevi CB . A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia. Tissue Antigens 2005; 65: 252–259.
Locatelli F, Velardi A, Giebel S . The role of NK alloreactivity on the outcome of patients who received transplants from unrelated volunteers in influenced by different disease- and transplant-related variables. Blood 2004; 103: 2862 (letter).
Leung W, Iyengar R, Turner V et al. Determinants of antileukemia effects of allogeneic NK cells. J Immunol 2004; 172: 644–650.
Acknowledgements
This project was supported, in part, by an academic improvement grant from City of Hope National Medical Center, donation from Evelyn Fox Schreiber Endowment, a generous grant from the Marcus Foundation, a BMT grant (NCI 30206), and a Cancer Center Grant (CA 33572-19S4) from National Cancer Institute. We thank Mary Ann Yorba for finding the samples.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sun, J., Gaidulis, L., Dagis, A. et al. Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML. Bone Marrow Transplant 36, 525–530 (2005). https://doi.org/10.1038/sj.bmt.1705089
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705089
Keywords
This article is cited by
-
KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted grafts
Annals of Hematology (2014)
-
Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation
Seminars in Immunopathology (2008)
-
The diversity of KIR gene in Chinese Northern Han population and the impact of donor KIR and patient HLA genotypes on outcome following HLA-identical sibling allogeneic hematopoietic stem cell transplantation for hematological malignancy in Chinese people
International Journal of Hematology (2008)